Cartilage-derived morphogenetic proteins induce osteogenic gene expression in the C2C12 mesenchymal cell line

Journal of Cellular Biochemistry

Volumn 95, Issue 1, 2005, Pages 173-188

  Yeh, Lee Chuan C ^a   Tsai, Alicia D ^a   Lee, John C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone morphogenetic proteins, BMPs; C2C12; Cartilage derived morphogenetic proteins, CDMPs; Gene expression; Growth differentiation factors, GDFs; Osteogenesis; Transforming growth factor , TGF

Indexed keywords

AGGRECAN; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN RECEPTOR IA; BONE MORPHOGENETIC PROTEIN RECEPTOR IIB; CARTILAGE DERIVED MORPHOGENETIC PROTEIN 2; CELL MARKER; CELL PROTEIN; COLLAGEN TYPE 1; GROWTH DIFFERENTIATION FACTOR 5; MESSENGER RNA; MYOD PROTEIN; OSTEOCALCIN; PROTEIN ACTR IA; PROTEIN ALK 7; SCLERAXIS; TENDIN; TRANSCRIPTION FACTOR SIX1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MESENCHYME CELL; MOLECULAR MODEL; MYOBLAST; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN INDUCTION; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECT; MESODERM; MOUSE; OSTEOBLAST; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; MESODERM; MICE; OSTEOBLASTS;

EID: 23844522605     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20402     Document Type: Article

References (47)

1. Aspenberg P, Forslund C. 1999. Enhanced tendon healing with GDF 5 and 6. Acta Orthop Scand 70:51-54.
2. Aspenberg P, Forslund C. 2000. Bone morphogenetic proteins and tendon repair [In Process Citation]. Scand J Med Sci Sports 10:372-375.
3. Banerjee C, Javed A, Choi JY, Green J, Rosen V, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2001. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142:4026-4039.
4. Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Chang SC, Hoang B, Thomas JT, Vukicevic S, Luyten FP, Ryba NJ, Kozak CA, Reddi AH, Moos M, Jr. 1994. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269:28227-28234.
6. Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE. 1997. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60:283-290.
7. Clark RT, Johnson TL, Schalet BJ, Davis L, Gaschen V, Hunziker EB, Oldberg A, Mikic B. 2001. GDF-5 deficiency in mice leads to disruption of tail tendon form and function. Connect Tissue Res 42:175-186.
8. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T. 1999. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112:3519-3527.
9. Erlacher L, McCartney J, Piek E, ten Dijke P, Yanagishita M, Oppermann H, Luyten FP. 1998. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J Bone Miner Res 13:383-392.
10. Francis-West PH, Parish J, Lee K, Archer CW. 1999. BMP/GDF-signalling interactions during synovial joint development. Cell Tissue Res 296:111-119.
11. Gruber R, Mayer C, Schulz W, Graninger W, Peterlik M, Watzek G, Luyten FP, Erlacher L. 2000. Stimulatory effects of cartilage-derived morphogenetic proteins 1 and 2 on osteogenic differentiation of bone marrow stromal cells [In Process Citation]. Cytokine 12:1630-1638.
12. Gruber R, Mayer C, Bobacz K, Krauth MT, Graninger W, Luyten FP, Erlacher L. 2001. Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology 142:2087-2094.
13. Hamrick MW, McPherron AC, Lovejoy CO, Hudson J. 2000. Femoral morphology and cross-sectional geometry of adult myostatin-deficient mice. Bone 27:343-349.
14. Honda Y, Knutsen R, Strong DD, Sampath TK, Baylink DJ, Mohan S. 1997. Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells. Calcif Tissue Int 60:297-301.
15. Hotten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, Tanaka H, Satoh Y, Okazaki M, Shirai T, Pan H, Kawai S, Pohl JS, Kudo A. 1996. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13:65-74.
16. Inada M, Katagiri T, Akiyama S, Namika M, Komaki M, Yamaguchi A, Kamoi K, Rosen V, Suda T. 1996. Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochem Biophys Res Commun 222:317-322.
17. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
18. Kingsley DM. 1994. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
19. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM. 1999. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73:114-125.
20. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. 2000. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20:8783-8792.
21. Liu Y, Watanabe H, Nifuji A, Yamada Y, Olson EN, Noda M. 1997. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem 272:29880-29885.
22. Lou J, Tu Y, Burns M, Silva MJ, Manske P. 2001. BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res 19:1199-1202.
23. Merino R, Macias D, Ganan Y, Economides AN, Wang X, Wu Q, Stahl N, Sampath KT, Varona P, Hurle JM. 1999. Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud. Dev Biol 206: 33-45.
24. Mikic B, Schalet BJ, Clark RT, Gaschen V, Hunziker EB. 2001. GDF-5 deficiency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 19:365-371.
25. Mikic B, Battaglia TC, Taylor EA, Clark RT. 2002. The effect of growth/differentiation factor-5 deficiency on femoral composition and mechanical behavior in mice. Bone 30:733-737.
26. Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T. 1997. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem 272:22046-22052.
27. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K. 1996. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352.
28. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S. 1999. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun 262:739-743.
29. Polinkovsky A, Robin NH, Thomas JT, Irons M, Lynn A, Goodman FR, Reardon W, Kant SG, Brunner HG, van der Burgt I, Chitayat D, McGaughran J, Donnai D, Luyten FP, Warman ML. 1997. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 17:18-19.
30. Rickert M, Jung M, Adiyaman M, Richter W, Simank HG. 2001. A growth and differentiation factor-5 (GDF-5)-coated suture stimulates tendon healing in an Achilles tendon model in rats. Growth Factors 19:115-126.
31. Salingcarnboriboon R, Yoshitake H, Tsuji K, Obinata M, Amagasa T, Nifuji A, Noda M. 2003. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 287:289-300.
32. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, Tabin CJ. 2001. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128:3855-3866.
33. Settle SH, Jr., Rountree RB, Sinha A, Thacker A, Higgins K, Kingsley DM. 2003. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and GdF5 genes. Dev Biol 254:116-130.
34. Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LC. 2003. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem 90:1112-1127.
35. Spiro RC, Liu L, Heidaran MA, Thompson AY, Ng CK, Pohl J, Poser JW. 2000. Inductive activity of recombinant human growth and differentiation factor-5. Biochem Soc Trans 28:362-368.
36. Storm EE, Kingsley DM. 1999. GDF5 coordinates bone and joint formation during digit development. Dev Biol 209:11-27.
37. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP. 1996. A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 12:315-317.
38. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, Luyten FP. 1997. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58-64.
39. Tsai AD, Yeh LC, Lee JC. 2003. Effects of osteogenic protein-1 (OP-1, BMP-7) on gene expression in cultured medial collateral ligament cells. J Cell Biochem 90:777-791.
40. Tsuji K, Ito Y, Noda M. 1998. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. Bone 22:87-92.
41. Tsumaki N, Tanaka K, Arikawa-Hirasawa E, Nakase T, Kimura T, Thomas JT, Ochi T, Luyten FP, Yamada Y. 1999. Role of CDMP-1 in skeletal morphogenesis: Promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 144:161-173.
42. Wolfman NM, Hattersley G, Cox K, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E, Nove J, Song JJ, Wozney JM, Rosen V. 1997. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest 100:321-330.
43. Yeh LC, Adamo ML, Olson MS, Lee JC. 1997. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138:4181-4190.
44. Yeh LC, Unda R, Lee JC. 2000. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol 185:87-97.
45. Yeh LC, Mallein-Gerin F, Lee JC. 2002a. Differential effects of osteogenic protein-1 (BMP-7) on gene expression of BMP and GDF family members during differentiation of the mouse MC615 chondrocyte cells. J Cell Physiol 191:298-309.
46. Yeh LC, Tsai AD, Lee JC. 2002b. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 87:292-304.
47. Yeh L-CC, Tsai AD, Zavala MC, Lee JC. 2004. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells. J Cell Physiol 201:401-408.